Abstract
Systemic corticosteroids (SCSs) have been widely used to treat various inflammatory respiratory diseases for many years despite the serious complications associated with them. Inhaled corticosteroids (ICSs) have been developed to reduce the harmful adverse effects of SCSs. Since their first introduction, ICSs have been used primarily for the treatment of asthma. However, certain individuals including those with chronic obstructive pulmonary disease or croup may respond to the beneficial effects of ICSs. In this review, we discuss the effectiveness of ICSs in the treatment of non-asthmatic inflammatory respiratory diseases in paediatric and adult populations.
Keywords: Adult, children, effectiveness, inflammation, inhaled corticosteroids, non-asthmatic respiratory diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Success of Inhaled Corticosteroids in the Treatment of Non-Asthmatic Respiratory Diseases
Volume: 11 Issue: 3
Author(s): Nazan Cobanoglu
Affiliation:
Keywords: Adult, children, effectiveness, inflammation, inhaled corticosteroids, non-asthmatic respiratory diseases
Abstract: Systemic corticosteroids (SCSs) have been widely used to treat various inflammatory respiratory diseases for many years despite the serious complications associated with them. Inhaled corticosteroids (ICSs) have been developed to reduce the harmful adverse effects of SCSs. Since their first introduction, ICSs have been used primarily for the treatment of asthma. However, certain individuals including those with chronic obstructive pulmonary disease or croup may respond to the beneficial effects of ICSs. In this review, we discuss the effectiveness of ICSs in the treatment of non-asthmatic inflammatory respiratory diseases in paediatric and adult populations.
Export Options
About this article
Cite this article as:
Cobanoglu Nazan, Success of Inhaled Corticosteroids in the Treatment of Non-Asthmatic Respiratory Diseases, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2012; 11 (3) . https://dx.doi.org/10.2174/1871523011202030210
DOI https://dx.doi.org/10.2174/1871523011202030210 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mechanistic Systems Biology of Inflammatory Gene Expression in Airway Smooth Muscle as Tool for Asthma Drug Development
Current Drug Discovery Technologies Efficacy of Andolast in Mild to Moderate Asthma: A Randomized, Controlled, Double-Blind Multicenter Study (The Andast Trial)
Current Pharmaceutical Design The Malignant Obesity Hypoventilation Syndrome (MOHS)
Current Respiratory Medicine Reviews SARS-CoV-2 Transmission Among Healthcare Workers in Iran: An Urgent Need for Early Identification and Management
Infectious Disorders - Drug Targets Ligand and Structure Based Models for the Identification of Beta 2 Adrenergic Receptor Antagonists
Current Computer-Aided Drug Design Chelating Agents for Metal Intoxication
Current Medicinal Chemistry The Role of Bacteria and Viruses in Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Data-driven Approach to Detect and Predict Adverse Drug Reactions
Current Pharmaceutical Design Patent Review
Combinatorial Chemistry & High Throughput Screening The Role of iNOS in Chronic Inflammatory Processes In Vivo: Is it Damage-Promoting, Protective, or Active at all?
Current Molecular Medicine Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: Past and Future Roles of 5-HT4 Receptor Agonists
Current Medicinal Chemistry - Central Nervous System Agents Editorial [Hot Topic: G-Protein-Coupled Receptors (GPCRs) and Drug Discovery (Guest Editor: Luca Gentilucci)]
Current Drug Targets Transient Receptor Potential Channels - Emerging Novel Drug Targets for the Treatment of Pain
Current Medicinal Chemistry Drug Repositioning: A Unique Approach to Refurbish Drug Discovery
Current Drug Discovery Technologies Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases
Current Alzheimer Research Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
Current Drug Targets The Chemical Defensive System in the Pathobiology of Idiopathic Environment- Associated Diseases
Current Drug Metabolism Neuroinflammation, Diabetes and COVID-19: Perspectives Coming from Ca<sup>2+</sup>/cAMP Signalling
Current Drug Research Reviews Pulmonary Function Tests in European Birth Cohorts
Current Respiratory Medicine Reviews Role of Plasmacytoid Dendritic Cells in Lung-Associated Inflammation
Recent Patents on Inflammation & Allergy Drug Discovery